Ahn-Gook Pharmaceutical Co., Ltd. (KOSDAQ: 001540)
South Korea
· Delayed Price · Currency is KRW
6,600.00
-20.00 (-0.30%)
Jan 22, 2025, 3:18 PM KST
Ahn-Gook Pharmaceutical Revenue
Ahn-Gook Pharmaceutical had revenue of 67.51B KRW in the quarter ending September 30, 2024, with 21.96% growth. This brings the company's revenue in the last twelve months to 264.64B, up 17.00% year-over-year. In the year 2023, Ahn-Gook Pharmaceutical had annual revenue of 233.68B with 13.77% growth.
Revenue (ttm)
264.64B
Revenue Growth
+17.00%
P/S Ratio
0.28
Revenue / Employee
661.59M
Employees
400
Market Cap
75.01B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 233.68B | 28.29B | 13.77% |
Dec 31, 2022 | 205.39B | 41.85B | 25.59% |
Dec 31, 2021 | 163.53B | 20.17B | 14.07% |
Dec 31, 2020 | 143.36B | -12.49B | -8.01% |
Dec 31, 2019 | 155.85B | -29.89B | -16.09% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |